Home/Pipeline/QLoci NIPT Panel

QLoci NIPT Panel

Prenatal screening for chromosomal aneuploidy

Clinical use (TFDA‑approved LDT)Active

Key Facts

Indication
Prenatal screening for chromosomal aneuploidy
Phase
Clinical use (TFDA‑approved LDT)
Status
Active
Company

About LifeOS Genomics

Taiwan‑based IVD firm delivering ultra‑sensitive multiplex liquid‑biopsy diagnostics via its mdPCR‑based QLoci platform.

View full company profile